We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-1.76%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$558M
AUM Growth
-$12.9M
Cap. Flow
+$5.56M
Cap. Flow %
1%
Top 10 Hldgs %
34.67%
Holding
718
New
53
Increased
127
Reduced
202
Closed
64

Top Buys

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$18.8M
2
TUR icon
iShares MSCI Turkey ETF
TUR
+$10.5M
3
STLA icon
Stellantis
STLA
+$8.61M
4
EWT icon
iShares MSCI Taiwan ETF
EWT
+$8.39M
5
UBS icon
UBS Group
UBS
+$7.64M

Sector Composition

Rank Sector Weight
1 Financials 16.61%
2 Consumer Discretionary 13.94%
3 Industrials 7.15%
4 Energy 7.06%
5 Healthcare 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPK icon
326
Opko Health
OPK
$929M
$80.3K 0.01%
38,416
+4,795
+14% +$9.8K
RCL icon
327
Royal Caribbean
RCL
$79.2B
$79.6K 0.01%
735
ZBRA icon
328
Zebra Technologies
ZBRA
$12.7B
$78.6K 0.01%
381
-59
-13% -$11.9K
STMP
329
DELISTED
Stamps.com, Inc.
STMP
$78K 0.01%
1,048
-4,100
-80% -$241K
BBAR icon
330
BBVA Argentina
BBAR
$3.92B
$76.8K 0.01%
17,734
SPG icon
331
Simon Property Group
SPG
$74.8B
$75K 0.01%
482
THO icon
332
Thor Industries
THO
$4.09B
$74.1K 0.01%
1,309
OFIX icon
333
Orthofix Medical
OFIX
$475M
$73.9K 0.01%
1,395
LGND icon
334
Ligand Pharmaceuticals
LGND
$6.03B
$71.7K 0.01%
1,154
PLD icon
335
Prologis
PLD
$137B
$71.6K 0.01%
840
-128
-13% -$10.6K
LQD icon
336
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
$71.3K 0.01%
1,520
NUS icon
337
Nu Skin
NUS
$248M
$71K 0.01%
1,670
FOLD
338
DELISTED
Amicus Therapeutics
FOLD
$70.6K 0.01%
8,800
EPZM
339
DELISTED
Epizyme, Inc
EPZM
$70.1K 0.01%
6,800
CORT icon
340
Corcept Therapeutics
CORT
$9.85B
$70K 0.01%
4,953
WPM icon
341
Wheaton Precious Metals
WPM
$50.6B
$68K 0.01%
2,592
ECH icon
342
iShares MSCI Chile ETF
ECH
$1,000M
$65.1K 0.01%
1,738
BUD icon
343
CALL
AB InBev
BUD
$155B
$63.2K 0.01%
853
+850
+28,333% +$80.7K
BDX icon
344
Becton Dickinson
BDX
$43.8B
$62.5K 0.01%
253
AIG icon
345
American International
AIG
$42.4B
$60.9K 0.01%
1,093
GEN icon
346
Gen Digital
GEN
$16B
$60.5K 0.01%
2,561
-5,400
-68% -$126K
BMRN icon
347
BioMarin Pharmaceuticals
BMRN
$11.7B
$60.2K 0.01%
893
-5
-0.6% -$385
PANW icon
348
Palo Alto Networks
PANW
$265B
$59.9K 0.01%
1,764
AGI icon
349
Alamos Gold
AGI
$12.4B
$58.9K 0.01%
10,154
-87,000
-90% -$581K
ALL icon
350
Allstate
ALL
$67.1B
$58.6K 0.01%
539

Similar funds

Exane Derivatives's Q3 2019 Portfolio in Review

As of Q3 2019, Exane Derivatives held 718 positions worth $558M, down 2.3% from $571M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Exane Derivatives's Q3 2019 filing shows 53 new, 127 increased, 202 reduced and 64 closed positions. Its largest new stake was iShares MSCI Turkey ETF: 416,930 shares worth $11.1M. The largest sale was PepsiCo, an estimated $23.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Exane Derivatives's largest Q3 2019 buy was iShares MSCI Turkey ETF: 416,930 shares worth $11.1M.
  • Exane Derivatives added most to Ferrari in Q3 2019, an estimated $18.8M increase.
  • Exane Derivatives's biggest Q3 2019 reduction was PepsiCo, cutting an estimated $23.2M.
  • Exane Derivatives fully exited IBM in Q3 2019, selling an estimated $3.47M.
  • Exane Derivatives's ten largest holdings make up 35% of its $558M portfolio in Q3 2019.
  • Exane Derivatives opened 53 new positions and closed 64 in Q3 2019.
  • Exane Derivatives's portfolio value fell 2.3% quarter-over-quarter to $558M.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.